BRIEF

on FSD Pharma Inc.

FSD Pharma Inc. Wins Final Judgment Against Dr. Raza Bokhari

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) secured a final judgment from the United States District Court for the Eastern District of Pennsylvania. The court confirmed the arbitration award, totaling USD $3,059,998 plus interest, against Dr. Raza Bokhari, who serves as Chairman and CEO of Medicus Pharma Ltd.

The judgment includes USD $147,301.04 and CAD $2,861,141.70 (spread across several claims), all accruing interest until satisfaction. This follows an arbitration ruling in Ontario, Canada, where Dr. Bokhari's termination by FSD was upheld.

The district court found no valid grounds under the New York Convention to deny enforcement of the arbitration awards. FSD Pharma intends to pursue all means to collect the awarded amounts from Dr. Bokhari.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all FSD Pharma Inc. news